1240 related articles for article (PubMed ID: 32043986)
1. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.
Villar J; Ferrando C; Martínez D; Ambrós A; Muñoz T; Soler JA; Aguilar G; Alba F; González-Higueras E; Conesa LA; Martín-Rodríguez C; Díaz-Domínguez FJ; Serna-Grande P; Rivas R; Ferreres J; Belda J; Capilla L; Tallet A; Añón JM; Fernández RL; González-Martín JM;
Lancet Respir Med; 2020 Mar; 8(3):267-276. PubMed ID: 32043986
[TBL] [Abstract][Full Text] [Related]
2. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.
Tomazini BM; Maia IS; Cavalcanti AB; Berwanger O; Rosa RG; Veiga VC; Avezum A; Lopes RD; Bueno FR; Silva MVAO; Baldassare FP; Costa ELV; Moura RAB; Honorato MO; Costa AN; Damiani LP; Lisboa T; Kawano-Dourado L; Zampieri FG; Olivato GB; Righy C; Amendola CP; Roepke RML; Freitas DHM; Forte DN; Freitas FGR; Fernandes CCF; Melro LMG; Junior GFS; Morais DC; Zung S; Machado FR; Azevedo LCP;
JAMA; 2020 Oct; 324(13):1307-1316. PubMed ID: 32876695
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial.
Villar J; Añón JM; Ferrando C; Aguilar G; Muñoz T; Ferreres J; Ambrós A; Aldecoa C; Suárez-Sipmann F; Thorpe KE; Jüni P; Slutsky AS;
Trials; 2020 Aug; 21(1):717. PubMed ID: 32799933
[TBL] [Abstract][Full Text] [Related]
4. Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
Dixon B; Smith RJ; Campbell DJ; Moran JL; Doig GS; Rechnitzer T; MacIsaac CM; Simpson N; van Haren FMP; Ghosh AN; Gupta S; Broadfield EJC; Crozier TME; French C; Santamaria JD;
Lancet Respir Med; 2021 Apr; 9(4):360-372. PubMed ID: 33493448
[TBL] [Abstract][Full Text] [Related]
5. Ultra-low tidal volume ventilation for COVID-19-related ARDS in France (VT4COVID): a multicentre, open-label, parallel-group, randomised trial.
Richard JC; Terzi N; Yonis H; Chorfa F; Wallet F; Dupuis C; Argaud L; Delannoy B; Thiery G; Pommier C; Abraham P; Muller M; Sigaud F; Rigault G; Joffredo E; Mezidi M; Souweine B; Baboi L; Serrier H; Rabilloud M; Bitker L;
Lancet Respir Med; 2023 Nov; 11(11):991-1002. PubMed ID: 37453445
[TBL] [Abstract][Full Text] [Related]
6. Personalised mechanical ventilation tailored to lung morphology versus low positive end-expiratory pressure for patients with acute respiratory distress syndrome in France (the LIVE study): a multicentre, single-blind, randomised controlled trial.
Constantin JM; Jabaudon M; Lefrant JY; Jaber S; Quenot JP; Langeron O; Ferrandière M; Grelon F; Seguin P; Ichai C; Veber B; Souweine B; Uberti T; Lasocki S; Legay F; Leone M; Eisenmann N; Dahyot-Fizelier C; Dupont H; Asehnoune K; Sossou A; Chanques G; Muller L; Bazin JE; Monsel A; Borao L; Garcier JM; Rouby JJ; Pereira B; Futier E;
Lancet Respir Med; 2019 Oct; 7(10):870-880. PubMed ID: 31399381
[TBL] [Abstract][Full Text] [Related]
7. Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome.
Gates S; Perkins GD; Lamb SE; Kelly C; Thickett DR; Young JD; McAuley DF; Snaith C; McCabe C; Hulme CT; Gao Smith F
Health Technol Assess; 2013 Sep; 17(38):v-vi, 1-87. PubMed ID: 24028755
[TBL] [Abstract][Full Text] [Related]
8. Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial.
McAuley DF; Cross LM; Hamid U; Gardner E; Elborn JS; Cullen KM; Dushianthan A; Grocott MP; Matthay MA; O'Kane CM
Lancet Respir Med; 2017 Jun; 5(6):484-491. PubMed ID: 28526233
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the efficacy of dexamethasone in the treatment of patients with persistent acute respiratory distress syndrome: study protocol for a randomized controlled trial.
Villar J; Belda J; Añón JM; Blanco J; Pérez-Méndez L; Ferrando C; Martínez D; Soler JA; Ambrós A; Muñoz T; Rivas R; Corpas R; Díaz-Dominguez FJ; Soro M; García-Bello MA; Fernández RL; Kacmarek RM;
Trials; 2016 Jul; 17():342. PubMed ID: 27449641
[TBL] [Abstract][Full Text] [Related]
10. Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.
Ranieri VM; Pettilä V; Karvonen MK; Jalkanen J; Nightingale P; Brealey D; Mancebo J; Ferrer R; Mercat A; Patroniti N; Quintel M; Vincent JL; Okkonen M; Meziani F; Bellani G; MacCallum N; Creteur J; Kluge S; Artigas-Raventos A; Maksimow M; Piippo I; Elima K; Jalkanen S; Jalkanen M; Bellingan G;
JAMA; 2020 Feb; 323(8):725-733. PubMed ID: 32065831
[TBL] [Abstract][Full Text] [Related]
11. COVID-19-associated ARDS treated with DEXamethasone (CoDEX): study design and rationale for a randomized trial.
Tomazini BM; Maia IS; Bueno FR; Silva MVAO; Baldassare FP; Costa ELV; Moura RAB; Honorato MO; Costa AN; Cavalcanti AB; Rosa RG; Avezum Á; Veiga VC; Lopes RD; Damiani LP; Machado FR; Berwanger O; Azevedo LCP;
Rev Bras Ter Intensiva; 2020; 32(3):354-362. PubMed ID: 33053024
[TBL] [Abstract][Full Text] [Related]
12. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome.
Needham CJ; Brindley PG
Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial.
François B; Jafri HS; Chastre J; Sánchez-García M; Eggimann P; Dequin PF; Huberlant V; Viña Soria L; Boulain T; Bretonnière C; Pugin J; Trenado J; Hernandez Padilla AC; Ali O; Shoemaker K; Ren P; Coenjaerts FE; Ruzin A; Barraud O; Timbermont L; Lammens C; Pierre V; Wu Y; Vignaud J; Colbert S; Bellamy T; Esser MT; Dubovsky F; Bonten MJ; Goossens H; Laterre PF;
Lancet Infect Dis; 2021 Sep; 21(9):1313-1323. PubMed ID: 33894131
[TBL] [Abstract][Full Text] [Related]
14. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial.
Matthay MA; Calfee CS; Zhuo H; Thompson BT; Wilson JG; Levitt JE; Rogers AJ; Gotts JE; Wiener-Kronish JP; Bajwa EK; Donahoe MP; McVerry BJ; Ortiz LA; Exline M; Christman JW; Abbott J; Delucchi KL; Caballero L; McMillan M; McKenna DH; Liu KD
Lancet Respir Med; 2019 Feb; 7(2):154-162. PubMed ID: 30455077
[TBL] [Abstract][Full Text] [Related]
15. Neuromuscular blockers in early acute respiratory distress syndrome.
Papazian L; Forel JM; Gacouin A; Penot-Ragon C; Perrin G; Loundou A; Jaber S; Arnal JM; Perez D; Seghboyan JM; Constantin JM; Courant P; Lefrant JY; Guérin C; Prat G; Morange S; Roch A;
N Engl J Med; 2010 Sep; 363(12):1107-16. PubMed ID: 20843245
[TBL] [Abstract][Full Text] [Related]
16. Effect of Titrating Positive End-Expiratory Pressure (PEEP) With an Esophageal Pressure-Guided Strategy vs an Empirical High PEEP-Fio2 Strategy on Death and Days Free From Mechanical Ventilation Among Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.
Beitler JR; Sarge T; Banner-Goodspeed VM; Gong MN; Cook D; Novack V; Loring SH; Talmor D;
JAMA; 2019 Mar; 321(9):846-857. PubMed ID: 30776290
[TBL] [Abstract][Full Text] [Related]
17. High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial.
Coudroy R; Frat JP; Ehrmann S; Pène F; Decavèle M; Terzi N; Prat G; Garret C; Contou D; Gacouin A; Bourenne J; Girault C; Vinsonneau C; Dellamonica J; Labro G; Jochmans S; Herbland A; Quenot JP; Devaquet J; Benzekri D; Vivier E; Nseir S; Colin G; Thevenin D; Grasselli G; Bougon D; Assefi M; Guérin C; Lherm T; Kouatchet A; Ragot S; Thille AW;
Lancet Respir Med; 2022 Jul; 10(7):641-649. PubMed ID: 35325620
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological characteristics, practice of ventilation, and clinical outcome in patients at risk of acute respiratory distress syndrome in intensive care units from 16 countries (PRoVENT): an international, multicentre, prospective study.
Neto AS; Barbas CSV; Simonis FD; Artigas-Raventós A; Canet J; Determann RM; Anstey J; Hedenstierna G; Hemmes SNT; Hermans G; Hiesmayr M; Hollmann MW; Jaber S; Martin-Loeches I; Mills GH; Pearse RM; Putensen C; Schmid W; Severgnini P; Smith R; Treschan TA; Tschernko EM; Melo MFV; Wrigge H; de Abreu MG; Pelosi P; Schultz MJ; ;
Lancet Respir Med; 2016 Nov; 4(11):882-893. PubMed ID: 27717861
[TBL] [Abstract][Full Text] [Related]
19. Effect of dexamethasone in patients with ARDS and COVID-19 (REMED trial)-study protocol for a prospective, multi-centre, open-label, parallel-group, randomized controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2022 Jan; 23(1):35. PubMed ID: 35033182
[TBL] [Abstract][Full Text] [Related]
20. Individualised, perioperative open-lung ventilation strategy during one-lung ventilation (iPROVE-OLV): a multicentre, randomised, controlled clinical trial.
Ferrando C; Carramiñana A; Piñeiro P; Mirabella L; Spadaro S; Librero J; Ramasco F; Scaramuzzo G; Cervantes O; Garutti I; Parera A; Argilaga M; Herranz G; Unzueta C; Vives M; Regi K; Costa-Reverte M; Sonsoles Leal M; Nieves-Alonso J; García E; Rodríguez-Pérez A; Fariña R; Cabrera S; Guerra E; Gallego-Ligorit L; Herrero-Izquierdo A; Vallés-Torres J; Ramos S; López-Herrera D; De La Matta M; Gokhan S; Kucur E; Mugarra A; Soro M; García L; Sastre JA; Aguirre P; Salazar CJ; Ramos MC; Morocho DR; Trespalacios R; Ezequiel-Fernández F; Lamanna A; Pia Cantatore L; Laforgia D; Bellas S; López C; Navarro-Ripoll R; Martínez S; Vallverdú J; Jacas A; Yepes-Temiño MJ; Belda FJ; Tusman G; Suárez-Sipmann F; Villar J;
Lancet Respir Med; 2024 Mar; 12(3):195-206. PubMed ID: 38065200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
